WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
WX was delisted on the 10th of December, 2015.
1 hedge funds and large institutions have $182K invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
164% more capital invested
Capital invested by funds: $69K → $182K (+$113K)
50% less funds holding
Funds holding: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HNB
Huntington National Bank
Columbus,
Ohio
|
+$182K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ninety One (UK)
London,
United Kingdom
|
-$67K |
| 2 |
CCS
Crosspoint Capital Strategies
Orinda,
California
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HNB
1
Huntington National Bank
Columbus,
Ohio
| $182K | +$182K | +4,694 | New |
|
|
2
Ninety One (UK)
London,
United Kingdom
| – | -$67K | -1,451 | Closed |
|
|
CCS
3
Crosspoint Capital Strategies
Orinda,
California
| – | -$2K | -63 | Closed |
|
WX Hedge Fund Activity: Q1 2016 in Review
1 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q1 2016, worth a combined $182K — up 164% from $69K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of WX and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was Huntington National Bank, opening a new position worth an estimated $182K. The largest seller was Ninety One (UK), exiting entirely with an estimated $67K sold.
- 1 institutional investor held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q1 2016, down from 2 in Q4 2015.
- Funds reported $182K of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q1 2016, up 164% quarter-over-quarter.
- 1 fund opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q1 2016 and 2 closed out, a net change of -1 holder.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q1 2016 was Huntington National Bank, an estimated $182K added.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q1 2016 was Ninety One (UK), an estimated $67K sold.
Based on aggregated 13F filings for Q1 2016.